Tcr2 Therapeutics Inc.: 25-NSE filed Jun 1, 2023

Form type
25-NSE
Filing date
Jun 1, 2023
Accession number
0001354457-23-000372
Filer
Tcr2 Therapeutics Inc. (CIK 1750019)